Article Details

Immix Biopharma Shares 49% Higher After Data in Connective Tissue Cancer Mice Study

Retrieved on: 2022-05-20 14:06:17

Tags for this article:

Click the tags to see associated articles and topics

Immix Biopharma Shares 49% Higher After Data in Connective Tissue Cancer Mice Study. View article details on HISWAI: https://www.marketwatch.com/story/immix-biopharma-shares-49-higher-after-data-in-connective-tissue-cancer-mice-study-271653055293%3Fmod%3Dnewsviewer_click

Excerpt

By Michael Dabaie Immix Biopharma Inc. shares rose 49% to $2.43 after it said IMX-110 showed improved survival over a U.S. Food and Drug...

Article found on: www.marketwatch.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up